Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patientsAkihiro Matsumoto, Shiro Iino, Hiromitsu Kumada et al.|Hepatology Research|2005Cited by 192
Low serum level of hepatitis B core‐related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapyAkihiro Matsumoto, Kendo Kiyosawa, Eiji Tanaka et al.|Hepatology Research|2007Cited by 83